Molecular and Clinical Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Isolates at a Tertiary Hospital in Wuhan, China

References

• Chen J, Yang Y, Yao H, et al. Prediction of prognosis in adult patients with carbapenem-resistant Klebsiella pneumoniae infection. Front Cell Infect Microbiol. 2022;11:818308. doi:10.3389/fcimb.2021.818308
   PubMed Web of Science ®Google Scholar
• Wang B, Pan F, Wang C, et al. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in a paediatric hospital in China. Int J Infect Dis. 2020;93:311–319. doi:10.1016/j.ijid.2020.02.009
   PubMed Web of Science ®Google Scholar
• Li Y, Shen H, Zhu C, Yu Y. Carbapenem-resistant Klebsiella pneumoniae infections among ICU admission patients in central China: prevalence and prediction model. BioMed Res Int. 2019;2019:9767313. doi:10.1155/2019/9767313
   PubMed Web of Science ®Google Scholar
• Kopotsa K, Mbelle NM, Osei Sekyere J. Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistant Klebsiella pneumoniae clinical strains. Microb Genom. 2020;6(12):mgen000474. doi:10.1099/mgen.0.000474
   PubMed Web of Science ®Google Scholar
• Wang YP, Chen YH, Hung IC, et al. Transporter genes and fosA associated with fosfomycin resistance in carbapenem-resistant Klebsiella pneumoniae. Front Microbiol. 2022;13:816806. doi:10.3389/fmicb.2022.816806
   PubMed Web of Science ®Google Scholar
• Zhu WM, Yuan Z, Zhou HY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9:23. doi:10.1186/s13756-020-0686-0
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252–275. doi:10.1093/femsre/fux013
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu C, Shen Z, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018. Emerg Microbes Infect. 2020;9(1):1771–1779. doi:10.1080/22221751.2020.1799721
   PubMed Web of Science ®Google Scholar
• Dai G, Xu Y, Kong H, Xie W, Wang H. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and associated clinical outcomes. Am J Transl Res. 2021;13(6):7276–7281.
   PubMed Web of Science ®Google Scholar
• Whole-genome sequencing of bacterial pathogens: the future of nosocomial outbreak analysis. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608882/. Accessed February 26, 2022.
   Google Scholar
• Wang D, Wang M, He T, et al. Molecular epidemiology and mechanism of Klebsiella pneumoniae resistance to ertapenem but not to other carbapenems in China. Front Microbiol. 2022;13:974990. doi:10.3389/fmicb.2022.974990
   PubMedGoogle Scholar
• Hou M, Chen N, Dong L, et al. Molecular epidemiology, clinical characteristics and risk factors for bloodstream infection of multidrug-resistant Klebsiella pneumoniae infections in pediatric patients from Tianjin, China. Infect Drug Resist. 2022;15:7015–7023. doi:10.2147/IDR.S389279
   PubMed Web of Science ®Google Scholar
• Cheng S, Fleres G, Chen L, et al. Within-host genotypic and phenotypic diversity of contemporaneous carbapenem-resistant Klebsiella pneumoniae from blood cultures of patients with bacteremia. mBio. 2022:e02906. doi:10.1128/mbio.02906-22
   PubMed Web of Science ®Google Scholar
• Brink AJ. Epidemiology of carbapenem-resistant gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609–616. doi:10.1097/QCO.0000000000000608
   PubMed Web of Science ®Google Scholar
• Li Z, Ding Z, Yang J, et al. Carbapenem-resistant Klebsiella pneumoniae in Southwest China: molecular characteristics and risk factors caused by KPC and NDM producers. Infect Drug Resist. 2021;14:3145–3158. doi:10.2147/IDR.S324244
   PubMed Web of Science ®Google Scholar
• Bassetti M, Akova M, Tumbarello M. Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better? Intensive Care Med. 2018;44(11):1982–1984. doi:10.1007/s00134-018-5390-7
   PubMed Web of Science ®Google Scholar
• Lee N-Y, Tsai C-S, Syue L-S. Treatment outcome of bacteremia due to non–carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae bacteremia: role of carbapenem combination therapy. Clin Ther. 2020;42(3):e33–e44. doi:10.1016/j.clinthera.2020.01.004
   PubMed Web of Science ®Google Scholar
• Luan YY, Chen YH, Li X, et al. Clinical characteristics and risk factors for critically ill patients with carbapenem-resistant Klebsiella pneumoniae (CrKP): a cohort study from developing country. Infect Drug Resist. 2021;14:5555–5562. doi:10.2147/IDR.S343489
   PubMed Web of Science ®Google Scholar
• Chi X, Hu G, Xu H, et al. Genomic analysis of A KPC-2-producing Klebsiella Pneumoniae ST11 outbreak from a teaching hospital in Shandong Province, China. Infect Drug Resist. 2019;12:2961–2969. doi:10.2147/IDR.S221788
   PubMed Web of Science ®Google Scholar
• Su S, Li C, Zhao Y, et al. Outbreak of KPC-2–producing Klebsiella pneumoniae ST76 isolates in an intensive care unit and neurosurgery unit. Microb Drug Resist. 2020;26(9):1009–1018. doi:10.1089/mdr.2019.0363
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
   PubMed Web of Science ®Google Scholar
• Zheng R, Zhang Q, Guo Y, et al. Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China. Ann Clin Microbiol Antimicrob. 2016;15:10. doi:10.1186/s12941-016-0124-6
   PubMed Web of Science ®Google Scholar
• Chiu SK, Ma L, Chan MC, et al. Carbapenem nonsusceptible Klebsiella pneumoniae in Taiwan: dissemination and increasing resistance of carbapenemase producers during 2012–2015. Sci Rep. 2018;8. doi:10.1038/s41598-018-26691-z
   Web of Science ®Google Scholar
• Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67. doi:10.1093/cid/cir202
   PubMed Web of Science ®Google Scholar
• Lu MC, Chen YT, Tang HL, et al. Transmission and evolution of OXA-48-producing Klebsiella pneumoniae ST11 in a single hospital in Taiwan. J Antimicrob Chemother. 2019:dkz431. doi:10.1093/jac/dkz431
   Google Scholar
• Huang W, Zhang J, Zeng L, et al. Carbapenemase production and epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae in Western Chongqing, China. Front Cell Infect Microbiol. 2022;11:775740. doi:10.3389/fcimb.2021.775740
   PubMed Web of Science ®Google Scholar
• Qin X, Wu S, Hao M, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Supplement_2):S206–S214. doi:10.1093/infdis/jiz622
   PubMedGoogle Scholar
• Zhang WX, Chen HY, Chen C, et al. Resistance phenotype and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Shanghai. Microb Drug Resist. 2021;27(10):1312–1318. doi:10.1089/mdr.2020.0390
   PubMed Web of Science ®Google Scholar
• Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 2014;22(12):686–696. doi:10.1016/j.tim.2014.09.003
   PubMed Web of Science ®Google Scholar
• Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.004
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang W, Zhao Z, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genom. 2019;20:822. doi:10.1186/s12864-019-6225-9
   PubMed Web of Science ®Google Scholar
• Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34. doi:10.1016/j.jgar.2021.02.020
   PubMed Web of Science ®Google Scholar
• Russo TA, Olson R, Fang CT, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776. doi:10.1128/JCM.00776-18
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang X, Wu Q, et al. Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob Resist Infect Control. 2019;8:166. doi:10.1186/s13756-019-0615-2
   PubMed Web of Science ®Google Scholar
• Yan Q, Zhou M, Zou M, Liu WE. Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China. Eur J Clin Microbiol Infect Dis. 2016;35(3):387–396. doi:10.1007/s10096-015-2551-2
   PubMed Web of Science ®Google Scholar
• Khalil MAF, Hager R, Abd-El Reheem F, et al. A study of the virulence traits of carbapenem-resistant Klebsiella pneumoniae isolates in a Galleria mellonella model. Microb Drug Resist. 2019;25(7):1063–1071. doi:10.1089/mdr.2018.0270
   PubMed Web of Science ®Google Scholar
• Lam MMC, Wick RR, Wyres KL, et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb Genom. 2018;4(9):e000196. doi:10.1099/mgen.0.000196
   PubMed Web of Science ®Google Scholar